Thanks, can't remember if Nigel posted it somewhere or not.
Meanwhile, back East . . .
>>BOSTON & MERIDEN, Conn.--(BUSINESS WIRE)--Aug. 21, 2001--PerkinElmer, Inc. (NYSE: PKI - news), a leading provider of life sciences solutions, and Packard BioScience Company (NASDAQ: PBSC - news), a global developer, manufacturer and marketer of drug discovery tools, jointly announced today that on August 27, 2001, they expect to mail to their respective stockholders their Joint Proxy Statement/Prospectus relating to PerkinElmer's proposed acquisition of Packard BioScience. PerkinElmer expects to hold its Special Meeting of Stockholders on September 26, 2001, and Packard BioScience expects to hold its Special Meeting of Stockholders on September 27, 2001. Accordingly, subject to approval of PerkinElmer and Packard BioScience stockholders, as well as customary closing conditions and regulatory approvals, PerkinElmer and Packard BioScience expect the transaction to close during the fourth quarter of 2001.
PerkinElmer and Packard BioScience also announced today that the Federal Trade Commission (FTC) has requested additional information regarding the transaction. PerkinElmer and Packard BioScience each said that it will comply with this second request as expeditiously as practicable in order to complete the transaction. PerkinElmer's acquisition of Packard BioScience is conditioned upon, among other things, the expiration or earlier termination of the applicable waiting period under the Hart Scott Rodino Act. Unless terminated earlier, the waiting period will expire at 11:59 p.m., Eastern Time, on the thirtieth calendar day (or the next business day if that day falls on a weekend or is a holiday) after the date on which PerkinElmer and Packard BioScience have substantially complied with the FTC's request for additional information.
Important Additional Information has been filed with the SEC
On August 17, 2001, PerkinElmer filed with the SEC an amendment to its Registration Statement on Form S-4 relating to PerkinElmer's proposed acquisition of Packard BioScience. The Registration Statement and the Joint Proxy Statement/Prospectus included in the Registration Statement contain important information about PerkinElmer, Packard BioScience, the transaction and related matters. Investors and security holders are urged to read the Registration Statement and the Joint Proxy Statement/Prospectus carefully.
Investors and security holders may obtain free copies of the Registration Statement and the Joint Proxy Statement/Prospectus and other documents filed with the SEC by PerkinElmer and Packard BioScience through the web site maintained by the SEC at www.sec.gov.
In addition, investors and security holders may obtain free copies of the Registration Statement and the Joint Proxy Statement/Prospectus from PerkinElmer by contacting Diane Basile at (781) 431-4306 or from Packard BioScience by contacting Wayne Richardson at (203) 639-2266.
PerkinElmer and Packard BioScience, and their respective directors and executive officers, may be deemed to be participants in the solicitation of proxies in respect of the transactions contemplated by the merger agreement relating to the proposed acquisition. Information regarding PerkinElmer's and Packard BioScience's directors and executive officers is contained in the Registration Statement and the Joint Proxy Statement/Prospectus.<<
snipped the Safe harbor boilerplate
Cheers, Tuck |
